| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
| 02/11/2004 | CN1474810A Substituted urea neuropeptide YY5 antagonists |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474700A Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome |
| 02/11/2004 | CN1474693A Use of thienopyrimidines |
| 02/11/2004 | CN1474688A Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists |
| 02/11/2004 | CN1473935A GST fusion expression of conotoxin MVII A gene and its use |
| 02/11/2004 | CN1473620A Capsule of cordyceps |
| 02/11/2004 | CN1473619A Chinese medicine health product preparation |
| 02/11/2004 | CN1473609A Oral liquid-green tea and sweet milk for preventing and treating hepatic and biliary diseases |
| 02/11/2004 | CN1473598A Medicinal pill for treating gastritis and its producing process |
| 02/11/2004 | CN1473597A Oral drip-pill of sarcandra glaber and preparing process |
| 02/11/2004 | CN1473593A Medicine for treating chronic diarrhea |
| 02/11/2004 | CN1473590A Chinese medicinal preparation for treating stomach swelling pain caused by splenic-gastric Qi stagnation and its preparing method |
| 02/11/2004 | CN1473587A Nutritive agent for gastrointestinal function |
| 02/11/2004 | CN1473581A External use antidiarrheal Chinese medicine for baby |
| 02/11/2004 | CN1473576A Sea-buckthorn whole fruit agent and its preparing method and use |
| 02/11/2004 | CN1473574A Medicine for preventing and curing hepatitis prepared from mudlump and its preparing |
| 02/11/2004 | CN1137987C Stomach fortifying liquor |
| 02/11/2004 | CN1137894C Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 02/11/2004 | CN1137888C Inhibitor of cysteninyl aspartic acid proteinase |
| 02/11/2004 | CN1137718C Chinese patent medicine for treating chronic colitis |
| 02/11/2004 | CN1137701C Capsule or tablet for treating viral hepatitis |
| 02/11/2004 | CN1137696C Medicine for treating hepatitis B and rheumatoid diseases |
| 02/11/2004 | CN1137692C Application of low-anticoagulant heparin and its derivatives in preparing medicines for preventing and treating liver fibrosis |
| 02/10/2004 | US6689804 Imidazo-imidazole |
| 02/10/2004 | US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 02/10/2004 | US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689783 Aryl oxime-piperazines useful as CCR5 antagonists |
| 02/10/2004 | US6689778 2-phenylamino-5-isoxazo-4-yl-pyrimidine derivatives |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/10/2004 | US6689764 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/10/2004 | US6689750 Bactericide compositions prepared and obtained from microccus varians |
| 02/10/2004 | US6689745 Agent for ameliorating pancreatic function disorder |
| 02/10/2004 | US6689741 Biocompatible polymers, process for their preparation and compositions containing them |
| 02/10/2004 | US6689562 Mammalian IAP gene family, primers, probes and detection methods |
| 02/10/2004 | US6689355 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 02/10/2004 | US6689350 Therapeutic polyesters and polyamides |
| 02/10/2004 | US6689341 Potassium phosphate and potassium carbonate, potassium fluoride, and/or potassium oxalate; calcium, strontium, silver, barium, and/or zinc salt; crystal complex |
| 02/10/2004 | US6689339 Freckles |
| 02/10/2004 | CA2291975C Quaternary ammonium compounds |
| 02/10/2004 | CA2272854C Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives |
| 02/10/2004 | CA2164951C Lipoxin compounds |
| 02/10/2004 | CA2108903C Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/05/2004 | WO2004011654A1 Novel serine protease |
| 02/05/2004 | WO2004011621A2 Multi-step method for the differentiation of insulin positive, glucose |
| 02/05/2004 | WO2004011468A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 02/05/2004 | WO2004011465A1 Kinase inhibitors |
| 02/05/2004 | WO2004011444A2 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 02/05/2004 | WO2004011443A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 02/05/2004 | WO2004011440A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredint |
| 02/05/2004 | WO2004011423A2 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | WO2004011402A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 02/05/2004 | WO2004011030A1 Medicinal composition for treating thrombopenia |
| 02/05/2004 | WO2004011028A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 02/05/2004 | WO2004011014A1 Ingestible material for the treatment of disease in the human digestive system |
| 02/05/2004 | WO2004011011A1 Oral and dental composition |
| 02/05/2004 | WO2004010995A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 02/05/2004 | WO2004010992A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 02/05/2004 | WO2004010974A2 Gelatin capsule exhibiting reduced cross-linking |
| 02/05/2004 | WO2004010973A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 02/05/2004 | WO2004010972A2 Pellicle-resistant gelatin capsule |
| 02/05/2004 | WO2004010961A1 Oral humectants |
| 02/05/2004 | WO2004010945A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 02/05/2004 | WO2003092589A3 Salt solution for colon cleansing |
| 02/05/2004 | WO2003084938A3 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases |
| 02/05/2004 | WO2003084560A3 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 02/05/2004 | WO2003080181A3 Storage stable eplerenone formulation |
| 02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
| 02/05/2004 | WO2003074654A3 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 02/05/2004 | WO2003066091A3 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 02/05/2004 | WO2003042397A3 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 02/05/2004 | WO2002041834A8 Atorvastatin hemi-calcium form vii |
| 02/05/2004 | US20040025199 Comprises g-protein couple receptors for identifying modulators of g-protein activity and diagnosis and treatment of infections, nervous system, tumor, autoimmune and inflammatory disorders |
| 02/05/2004 | US20040024218 Novel compounds |
| 02/05/2004 | US20040024215 Such as 4'-trifluoromethyl-biphenyl-2-carboxylic acid(4-(4-(alpha-methyl-benzyl)-piperazin-1-yl)-phenyl)-amide; apoprotein B-100 (apoB-100) and microsomal triglyceride transfer protein (MTP) |
| 02/05/2004 | US20040024208 Cyclic protein tyrosine kinase inhibitors |
| 02/05/2004 | US20040024179 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 02/05/2004 | US20040024062 Inhibiting a condition mediated by the alpha v beta 3 or alpha v beta 5 integrin; antitumor, -metastasis, -arthritic agents; angiogenesis, inhibitors; osteoporosis, humoral hypercalcemia of malignancy, smooth muscle cell migration |
| 02/05/2004 | US20040024060 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/05/2004 | US20040024057 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications |
| 02/05/2004 | US20040024056 Especially Cryptotanshinone and Dihydortanshinone; treatment of chronic hepatitis and hepatocirrhosis |
| 02/05/2004 | US20040024034 For modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus |
| 02/05/2004 | US20040024030 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |
| 02/05/2004 | US20040024023 1-Heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/05/2004 | US20040024014 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
| 02/05/2004 | US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/05/2004 | US20040023998 2-(5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidyl)-N-(1-(2-(5-t -butyl-1,3,4-oxadiazolyl)carbonyl)-2-(R,S)-methylpropyl) acetamide; elastase inhibitors |
| 02/05/2004 | US20040023996 Methods and compositions utilizing quinazolinones |
| 02/05/2004 | US20040023992 Antiinflammatory agents |
| 02/05/2004 | US20040023990 Use of pyrazolo[4,3-d]pyrimidines |
| 02/05/2004 | US20040023974 Pharmacological agents which are inhibitors of PTPases, in particular, the compounds of formula I inhibit PTP-1B and TC PTP, and thus may be employed for the treatment of conditions associated with PTPase activity. The compounds of the present |
| 02/05/2004 | US20040023973 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. |
| 02/05/2004 | US20040023963 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 02/05/2004 | US20040023960 Mammalian metabolites of the compound 2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3- (4-fluoro) phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo) methylmorpholine which is a tachykinin receptor antagonist as antiemetics |
| 02/05/2004 | US20040023954 Hypotensive drugs Bimatoprost, Latanaprost, Unoprostone, Travoprost and prostaglandin H2 1-ethanolamide or of structurally closely related analogs, are pro-drugs which hydrolyze under physiological conditions to provide |
| 02/05/2004 | US20040023950 N-heterocyclic derivatives as NOS inhibitors |
| 02/05/2004 | US20040023945 Cyclic amp-specific phosphodiesterase inhibitors |